Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/12957
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPalani C.D.
dc.contributor.authorRamanathapuram L.
dc.contributor.authorLam-ubol A.
dc.contributor.authorKurago Z.B.
dc.date.accessioned2021-04-05T03:21:54Z-
dc.date.available2021-04-05T03:21:54Z-
dc.date.issued2018
dc.identifier.issn19492553
dc.identifier.other2-s2.0-85040926472
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/12957-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85040926472&doi=10.18632%2foncotarget.23784&partnerID=40&md5=aa102c790c21eb7cfd4b825115e02391
dc.description.abstractPatient treatment for oral squamous cell carcinoma (OSCC) not associated with Human papillomavirus remains problematic. OSCC microenvironment is typically inflamed and colonized by microorganisms, providing ligands for toll-like receptors (TLR). In immune cells TLR2 and TLR4 activate NF-kB and extracellular signal regulated kinase (ERK)1/2 pathways, leading to upregulation of inhibitory adenosine receptors A2a and A2b, and reduction in stimulatory A1 and A3. How TLR and adenosine receptors function in SCC cells is not understood. To address this gap, we evaluated TLR and adenosine receptor expression and function in human OSCC cells and keratinocytes. TLR2 and A2a were co-expressed in pre-cancer and SCC cells of 17 oral specimens. In vitro, 5/6 OSCC lines expressed more TLR2 than TLR1, 4 or 6 mRNA. TLR2 ligands stimulated A2a expression in TLR2-high cell lines, but no A1 or A3 was detected with or without stimuli. In TLR2-high OSCC, TLR2/1, 2/6 and adenosine receptor agonists activated ERK1/2. TLR2-mediated ERK1/2 phosphorylation resulted in accumulation of c-FOS, ERK-dependent cell proliferation and reduced caspase-3 activity. Similar ERK1/2-dependent proliferation and decreased caspase-3 activity were caused by combined TLR2 and adenosine receptor stimuli. We conclude that TLR2 and adenosine receptor agonists, known to be present in the tumor microenvironment, may contribute to OSCC progression in part via direct effects on the ERK1/2 pathway in squamous carcinoma cells. © Palani et al.
dc.subjectadenosine A2a receptor
dc.subjectcaspase 3
dc.subjectmessenger RNA
dc.subjectmitogen activated protein kinase 1
dc.subjectmitogen activated protein kinase 3
dc.subjectprotein c fos
dc.subjecttoll like receptor 1
dc.subjecttoll like receptor 2
dc.subjecttoll like receptor 4
dc.subjecttoll like receptor 6
dc.subjectArticle
dc.subjectbioaccumulation
dc.subjectcancer growth
dc.subjectcell proliferation
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectenzyme activation
dc.subjectenzyme activity
dc.subjectenzyme phosphorylation
dc.subjecthuman
dc.subjecthuman cell
dc.subjecthuman tissue
dc.subjectin vitro study
dc.subjectkeratinocyte
dc.subjectmouth squamous cell carcinoma
dc.subjectoral squamous cell carcinoma cell line
dc.subjectprotein expression
dc.subjectprotein function
dc.subjectprotein induction
dc.subjectTLR signaling
dc.subjecttumor promotion
dc.titleToll-like recepwtor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases 1/2
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationOncotarget. Vol 9, No.6 (2018), p.6814-6829
dc.identifier.doi10.18632/oncotarget.23784
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.